Kyungbo Pharm: Revenue Up but Operating Profit Plunges 66%, Net Profit Down 98%
Sales increased to KRW 264.1 billion (+10.7%), but operating profit plunged to KRW 3.5 billion (-66.3%) and net profit to KRW 0.1 billion (-97.7%) due to new facility investments and R&D expenses.
Total assets: KRW 319.2 billion, total liabilities: KRW 173.8 billion, total equity: KRW 145.4 billion (no capital erosion).
These financial statements are unaudited and subject to change.
KOSPI Filing Information
Filing: Change in Sales or Profit Structure of 30% (15% for Large Corporations) or More (Key Management Matters of Subsidiary)